KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Times Interest Earned (2016 - 2020)

Nektar Therapeutics (NKTR) has 11 years of Times Interest Earned data on record, last reported at -$120.11 in Q2 2020.

  • For Q2 2020, Times Interest Earned fell 466.17% year-over-year to -$120.11; the TTM value through Mar 2021 reached -$619.59, down 2948.56%, while the annual FY2020 figure was -$62.05, 200.5% down from the prior year.
  • Times Interest Earned reached -$120.11 in Q2 2020 per NKTR's latest filing, down from -$21.54 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $180.8 in Q2 2018 and bottomed at -$120.11 in Q2 2020.
  • Average Times Interest Earned over 5 years is -$7.09, with a median of -$13.16 recorded in 2017.
  • Peak YoY movement for Times Interest Earned: plummeted 5977.31% in 2016, then soared 2066.6% in 2018.
  • A 5-year view of Times Interest Earned shows it stood at -$5.79 in 2016, then rose by 26.33% to -$4.27 in 2017, then crashed by 334.1% to -$18.52 in 2018, then dropped by 9.05% to -$20.2 in 2019, then plummeted by 494.63% to -$120.11 in 2020.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were -$120.11 in Q2 2020, -$21.54 in Q1 2020, and -$20.2 in Q4 2019.